120 related articles for article (PubMed ID: 28108733)
1. Systematic analysis of molecular mechanisms for HCC metastasis via text mining approach.
Zhen C; Zhu C; Chen H; Xiong Y; Tan J; Chen D; Li J
Oncotarget; 2017 Feb; 8(8):13909-13916. PubMed ID: 28108733
[TBL] [Abstract][Full Text] [Related]
2. Systematic analysis of ovarian cancer platinum-resistance mechanisms via text mining.
Li H; Li J; Gao W; Zhen C; Feng L
J Ovarian Res; 2020 Mar; 13(1):27. PubMed ID: 32160916
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus protein interaction network for HCV clearance and association of DAA to HCC occurrence via data mining approach: A systematic review and critical analysis.
Sghaier I; Brochot E; Loueslati BY; Almawi WY
Rev Med Virol; 2019 Mar; 29(2):e2033. PubMed ID: 30614131
[TBL] [Abstract][Full Text] [Related]
4. A personalized approach identifies disturbed pathways and key genes in hepatitis C virus-cirrhosis with hepatocellular carcinoma.
Li YL; Zheng MX; Wang G
Eur Rev Med Pharmacol Sci; 2016 Oct; 20(20):4266-4273. PubMed ID: 27831648
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatics Analysis Reveals Distinct Molecular Characteristics of Hepatitis B-Related Hepatocellular Carcinomas from Very Early to Advanced Barcelona Clinic Liver Cancer Stages.
Kong FY; Wei X; Zhou K; Hu W; Kou YB; You HJ; Liu XM; Zheng KY; Tang RX
PLoS One; 2016; 11(7):e0158286. PubMed ID: 27454179
[TBL] [Abstract][Full Text] [Related]
6. Systematic Analysis of Endometrial Cancer-Associated Hub Proteins Based on Text Mining.
Gao H; Zhang Z
Biomed Res Int; 2015; 2015():615825. PubMed ID: 26366417
[TBL] [Abstract][Full Text] [Related]
7. Alterations of oncogenes, tumor suppressor genes and growth factors in hepatocellular carcinoma: with relation to tumor size and invasiveness.
Tang Z; Qin L; Wang X; Zhou G; Liao Y; Weng Y; Jiang X; Lin Z; Liu K; Ye S
Chin Med J (Engl); 1998 Apr; 111(4):313-8. PubMed ID: 10374394
[TBL] [Abstract][Full Text] [Related]
8. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
[TBL] [Abstract][Full Text] [Related]
9. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis.
Mou T; Zhu D; Wei X; Li T; Zheng D; Pu J; Guo Z; Wu Z
World J Surg Oncol; 2017 Mar; 15(1):63. PubMed ID: 28302149
[TBL] [Abstract][Full Text] [Related]
10. Identification of AKT kinases as unfavorable prognostic factors for hepatocellular carcinoma by a combination of expression profile, interaction network analysis and clinical validation.
Zhang Y; Guo X; Yang M; Yu L; Li Z; Lin N
Mol Biosyst; 2014 Feb; 10(2):215-22. PubMed ID: 24247267
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of cell cycle and material metabolism related genes contributes to hepatocellular carcinoma occurrence.
Yan H; Li Z; Shen Q; Wang Q; Tian J; Jiang Q; Gao L
Pathol Res Pract; 2017 Apr; 213(4):316-321. PubMed ID: 28238542
[TBL] [Abstract][Full Text] [Related]
12. The gene expression profiling of hepatocellular carcinoma by a network analysis approach shows a dominance of intrinsically disordered proteins (IDPs) between hub nodes.
Singh S; Colonna G; Di Bernardo G; Bergantino F; Cammarota M; Castello G; Costantini S
Mol Biosyst; 2015 Nov; 11(11):2933-45. PubMed ID: 26267014
[TBL] [Abstract][Full Text] [Related]
13. Transcriptome and proteome of human hepatocellular carcinoma reveal shared metastatic pathways with significant genes.
Shen H; Zhong F; Zhang Y; Yu H; Liu Y; Qin L; He F; Tang Z; Yang P
Proteomics; 2015 Jun; 15(11):1793-800. PubMed ID: 25652264
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo.
Wang W; Wu F; Fang F; Tao Y; Yang L
Clin Cancer Res; 2008 Nov; 14(21):6804-12. PubMed ID: 18980974
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of hepatocellular carcinoma and cirrhosis gene expression profiles.
Jiang M; Zeng Q; Dai S; Liang H; Dai F; Xie X; Lu K; Gao C
Mol Med Rep; 2017 Jan; 15(1):380-386. PubMed ID: 27959423
[TBL] [Abstract][Full Text] [Related]
16. Identification of MicroRNAs and target genes involvement in hepatocellular carcinoma with microarray data.
Wang D; Tan J; Xu Y; Tan X; Han M; Tu Y; Zhu Z; Zen J; Dou C; Cai S
Hepatogastroenterology; 2015; 62(138):378-82. PubMed ID: 25916067
[TBL] [Abstract][Full Text] [Related]
17. MiR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA.
Wang M; Zhang J; Tong L; Ma X; Qiu X
Int J Clin Exp Pathol; 2015; 8(11):14110-20. PubMed ID: 26823724
[TBL] [Abstract][Full Text] [Related]
18. Identifying hepatocellular carcinoma-related genes and pathways by system biology analysis.
Wang P; Ouyang L; Zheng L; Wang Z
Ir J Med Sci; 2015 Jun; 184(2):357-64. PubMed ID: 24744259
[TBL] [Abstract][Full Text] [Related]
19. Strong correlation between ASPM gene expression and HCV cirrhosis progression identified by co-expression analysis.
Wang F; Chang Y; Li J; Wang H; Zhou R; Qi J; Liu J; Zhao Q
Dig Liver Dis; 2017 Jan; 49(1):70-76. PubMed ID: 27876500
[TBL] [Abstract][Full Text] [Related]
20. ANGPTL2 promotes tumor metastasis in hepatocellular carcinoma.
Gao L; Ge C; Fang T; Zhao F; Chen T; Yao M; Li J; Li H
J Gastroenterol Hepatol; 2015 Feb; 30(2):396-404. PubMed ID: 25090954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
